🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

34 results for “Alaunos Therapeutics” Clear

  1. Carboplatin

    Alaunos Therapeutics

    Extensive-Stage Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  2. doxorubicin in combination with palifosfamide-tris

    Alaunos Therapeutics

    Soft Tissue Sarcoma

    phase 3 small molecule completed

    1 trial

  3. Ad-RTS-hIL-12

    Alaunos Therapeutics

    Metastatic Breast Cancer

    phase 2 mab terminated

    1 trial

  4. Ad-RTS-hIL-12

    Alaunos Therapeutics

    Pediatric Brain Tumor

    phase 2 mab terminated

    1 trial

  5. Ad-RTS-hIL-12

    Alaunos Therapeutics

    Glioblastoma

    phase 2 mab completed

    3 trials

  6. Ad-RTS-hIL-12 and Veledimex

    Alaunos Therapeutics

    Breast Cancer Nos Metastatic Recurrent

    phase 2 gene therapy terminated

    1 trial

  7. Darinaparsin

    Alaunos Therapeutics

    Hematologic Neoplasms

    phase 2 small molecule completed

    1 trial

  8. Darinaparsin

    Alaunos Therapeutics

    HEPATOCELLULAR CARCINOMA

    phase 2 small molecule active

    1 trial

  9. Darinaparson

    Alaunos Therapeutics

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

  10. INXN-2001

    Alaunos Therapeutics

    Melanoma

    phase 2 mab completed

    1 trial

  11. Indibulin

    Alaunos Therapeutics

    Metastatic Breast Cancer

    phase 2 small molecule active

    1 trial

  12. Neoantigen specific TCR-T cell drug product

    Alaunos Therapeutics

    Gynecologic Cancer

    phase 2 mab terminated

    1 trial

  13. Palifosfamide Tris and Doxorubicin

    Alaunos Therapeutics

    Soft Tissue Sarcoma

    phase 2 small molecule active

    1 trial

  14. ZIO-101 (Darinaparsin)

    Alaunos Therapeutics

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  15. ZIO-201

    Alaunos Therapeutics

    Advanced Sarcoma

    phase 2 small molecule completed

    1 trial

  16. indibulin

    Alaunos Therapeutics

    Advanced Solid Tumors

    phase 2 small molecule active

    2 trials

  17. palifosfamide

    Alaunos Therapeutics

    Adult Central Nervous System Germ Cell Tumor

    phase 2 small molecule terminated

    1 trial

  18. Ad-RTS-hIL-12

    Alaunos Therapeutics

    Glioblastoma Multiforme

    phase 1 mab completed

    1 trial

  19. IL-2

    Alaunos Therapeutics

    Lymphoma

    phase 1 small molecule completed

    1 trial

  20. INXN-1001

    Alaunos Therapeutics

    Melanoma

    phase 1 small molecule completed

    1 trial

  21. ZIO-101

    Alaunos Therapeutics

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  22. ZIO-101 (Darinaparsin)

    Alaunos Therapeutics

    Acute Leukemia

    phase 1 small molecule completed

    1 trial

  23. ZIO-101 (Darinaparsin)

    Alaunos Therapeutics

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  24. ZIO-101-C (Darinaparsin)

    Alaunos Therapeutics

    Advanced Cancer

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources